Our partners, GenesisCare, now offer Theranostics here at Waratah Private. This evolving approach to cancer management combines diagnostic imaging and radionuclide therapy. To date, Theranostics has been most successfully used for metastatic castrate-resistant prostate cancer and advanced neuroendocrine tumours (NETs). Theranostics may also be an option for metastatic disease unresponsive to or unsuitable for conventional therapies. Access for these patients is via the TGA Special Access Scheme.
Contact firstname.lastname@example.org for further information about this treatment.